WCLC 2011: Low-dose Spiral CT Screening for Lung Cancer
Posted Aug 10 2011 11:48pm
Of course, the recently published study of the National Lung Cancer Screening Trial in NEJM on low-dose spiral CT for lung cancer screening in high-risk individuals received the spotlight at the commencement of the WCLC meeting. Dr. John Field, Chair of IASLC CT Screening Task Force, hailed the results as transformative for the field of lung cancer and framed the discussion in terms of making a transition to implementation. One of the study’s co-authors, Dr. Denise Aberle, noted that while the trial recorded 24% positive screens compared with 6.9% for chest radiographs, it also had a 95% false positive rate. A panel discussing the study concurred that the opportunity for early detection outweighs the potential physical and psychological burden of a false result.